APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tyrosine Protein Kinase JAK1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tyrosine Protein Kinase JAK1 Industry Growth and Trends Forecast to 2032

22 December 2025113 pages

Choose your research edition.

Industry ResearchTyrosine Protein Kinase JAK1 Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Tyrosine Protein Kinase JAK1 Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Tyrosine Protein Kinase JAK1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tyrosine Protein Kinase JAK1 Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Tyrosine Protein Kinase JAK1 Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Tyrosine Protein Kinase JAK1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tyrosine Protein Kinase JAK1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tyrosine Protein Kinase JAK1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tyrosine Protein Kinase JAK1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tyrosine Protein Kinase JAK1 include Eli Lilly and Co, Jiangsu Hengrui Medicine Co Ltd, Pfizer Inc, AbbVie Inc, AstraZeneca Plc, Vectura Group Plc, Theravance Biopharma Inc, Sareum Holdings Plc and Portola Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tyrosine Protein Kinase JAK1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tyrosine Protein Kinase JAK1 market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tyrosine Protein Kinase JAK1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tyrosine Protein Kinase JAK1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tyrosine Protein Kinase JAK1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tyrosine Protein Kinase JAK1 Market by Company

Eli Lilly and Co

Jiangsu Hengrui Medicine Co Ltd

Pfizer Inc

AbbVie Inc

AstraZeneca Plc

Vectura Group Plc

Theravance Biopharma Inc

Sareum Holdings Plc

Portola Pharmaceuticals Inc

Nissan Chemical Industries Ltd

Japan Tobacco Inc

Incyte Corp

Galapagos NV

Concert Pharmaceuticals Inc

CJ HealthCare Corp

Chipscreen Biosciences Ltd

Bristol-Myers Squibb Co

Astellas Pharma Inc

Aclaris Therapeutics Inc

Tyrosine Protein Kinase JAK1 Segment by Type

AZD-4205

CJ-15314

Cerdulatinib

Baricitinib

Others

Tyrosine Protein Kinase JAK1 Segment by Application

Eosinophilia

Cutaneous Lupus Erythematosus

Hairy Cell Leukemia

Others

Tyrosine Protein Kinase JAK1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tyrosine Protein Kinase JAK1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tyrosine Protein Kinase JAK1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tyrosine Protein Kinase JAK1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tyrosine Protein Kinase JAK1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tyrosine Protein Kinase JAK1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of AZD-4205 Table 2. Major Company of CJ-15314 Table 3. Major Company of Cerdulatinib Table 4. Major Company of Baricitinib Table 5. Major Company of Others Table 6. Global Tyrosine Protein Kinase JAK1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (k units) Table 8. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Type (2021-2026) Table 11. Global Tyrosine Protein Kinase JAK1 Price by Type (2021-2026) & (US$/unit) Table 12. Global Tyrosine Protein Kinase JAK1 Sales by Type (2027-2032) & (k units) Table 13. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Tyrosine Protein Kinase JAK1 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Type (2027-2032) Table 16. Global Tyrosine Protein Kinase JAK1 Price by Type (2027-2032) & (US$/unit) Table 17. North America Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (k units) Table 18. North America Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (k units) Table 20. Europe Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (k units) Table 24. Latin America Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Type (2021-2026) & (US$ Million) Table 27. Tyrosine Protein Kinase JAK1 Industry Trends Table 28. Tyrosine Protein Kinase JAK1 Industry Drivers Table 29. Tyrosine Protein Kinase JAK1 Industry Opportunities and Challenges Table 30. Tyrosine Protein Kinase JAK1 Industry Restraints Table 31. Global Tyrosine Protein Kinase JAK1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Company (2021-2026) Table 33. Global Tyrosine Protein Kinase JAK1 Sales by Company (2021-2026) & (k units) Table 34. Global Tyrosine Protein Kinase JAK1 Sales Share by Company (2021-2026) Table 35. Global Tyrosine Protein Kinase JAK1 Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Tyrosine Protein Kinase JAK1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Tyrosine Protein Kinase JAK1 Major Company Production Sites and Headquarters Table 38. Global Tyrosine Protein Kinase JAK1 Company, Product Type & Application Table 39. Global Tyrosine Protein Kinase JAK1 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Tyrosine Protein Kinase JAK1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Tyrosine Protein Kinase JAK1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Tyrosine Protein Kinase JAK1 Sales by Region (2021-2026) & (k units) Table 44. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Tyrosine Protein Kinase JAK1 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Region (2021-2026) Table 47. Global Tyrosine Protein Kinase JAK1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Tyrosine Protein Kinase JAK1 Sales by Region (2027-2032) & (k units) Table 49. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Tyrosine Protein Kinase JAK1 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Region (2027-2032) Table 52. Global Tyrosine Protein Kinase JAK1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Tyrosine Protein Kinase JAK1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (k units) Table 55. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Application (2021-2026) Table 58. Global Tyrosine Protein Kinase JAK1 Price by Application (2021-2026) & (US$/unit) Table 59. Global Tyrosine Protein Kinase JAK1 Sales by Application (2027-2032) & (k units) Table 60. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Tyrosine Protein Kinase JAK1 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Application (2027-2032) Table 63. Global Tyrosine Protein Kinase JAK1 Price by Application (2027-2032) & (US$/unit) Table 64. North America Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (k units) Table 65. North America Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (k units) Table 67. Europe Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (k units) Table 71. Latin America Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Application (2021-2026) & (US$ Million) Table 74. Eli Lilly and Co Company Information Table 75. Eli Lilly and Co Business Overview Table 76. Eli Lilly and Co Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Eli Lilly and Co Tyrosine Protein Kinase JAK1 Product Portfolio Table 78. Eli Lilly and Co Recent Development Table 79. Jiangsu Hengrui Medicine Co Ltd Company Information Table 80. Jiangsu Hengrui Medicine Co Ltd Business Overview Table 81. Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Product Portfolio Table 83. Jiangsu Hengrui Medicine Co Ltd Recent Development Table 84. Pfizer Inc Company Information Table 85. Pfizer Inc Business Overview Table 86. Pfizer Inc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Pfizer Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 88. Pfizer Inc Recent Development Table 89. AbbVie Inc Company Information Table 90. AbbVie Inc Business Overview Table 91. AbbVie Inc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. AbbVie Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 93. AbbVie Inc Recent Development Table 94. AstraZeneca Plc Company Information Table 95. AstraZeneca Plc Business Overview Table 96. AstraZeneca Plc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. AstraZeneca Plc Tyrosine Protein Kinase JAK1 Product Portfolio Table 98. AstraZeneca Plc Recent Development Table 99. Vectura Group Plc Company Information Table 100. Vectura Group Plc Business Overview Table 101. Vectura Group Plc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Vectura Group Plc Tyrosine Protein Kinase JAK1 Product Portfolio Table 103. Vectura Group Plc Recent Development Table 104. Theravance Biopharma Inc Company Information Table 105. Theravance Biopharma Inc Business Overview Table 106. Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 108. Theravance Biopharma Inc Recent Development Table 109. Sareum Holdings Plc Company Information Table 110. Sareum Holdings Plc Business Overview Table 111. Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Product Portfolio Table 113. Sareum Holdings Plc Recent Development Table 114. Portola Pharmaceuticals Inc Company Information Table 115. Portola Pharmaceuticals Inc Business Overview Table 116. Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 118. Portola Pharmaceuticals Inc Recent Development Table 119. Nissan Chemical Industries Ltd Company Information Table 120. Nissan Chemical Industries Ltd Business Overview Table 121. Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Product Portfolio Table 123. Nissan Chemical Industries Ltd Recent Development Table 124. Japan Tobacco Inc Company Information Table 125. Japan Tobacco Inc Business Overview Table 126. Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 128. Japan Tobacco Inc Recent Development Table 129. Incyte Corp Company Information Table 130. Incyte Corp Business Overview Table 131. Incyte Corp Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Incyte Corp Tyrosine Protein Kinase JAK1 Product Portfolio Table 133. Incyte Corp Recent Development Table 134. Galapagos NV Company Information Table 135. Galapagos NV Business Overview Table 136. Galapagos NV Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Galapagos NV Tyrosine Protein Kinase JAK1 Product Portfolio Table 138. Galapagos NV Recent Development Table 139. Concert Pharmaceuticals Inc Company Information Table 140. Concert Pharmaceuticals Inc Business Overview Table 141. Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 143. Concert Pharmaceuticals Inc Recent Development Table 144. CJ HealthCare Corp Company Information Table 145. CJ HealthCare Corp Business Overview Table 146. CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Product Portfolio Table 148. CJ HealthCare Corp Recent Development Table 149. Chipscreen Biosciences Ltd Company Information Table 150. Chipscreen Biosciences Ltd Business Overview Table 151. Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Product Portfolio Table 153. Chipscreen Biosciences Ltd Recent Development Table 154. Bristol-Myers Squibb Co Company Information Table 155. Bristol-Myers Squibb Co Business Overview Table 156. Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 157. Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Product Portfolio Table 158. Bristol-Myers Squibb Co Recent Development Table 159. Astellas Pharma Inc Company Information Table 160. Astellas Pharma Inc Business Overview Table 161. Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 162. Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 163. Astellas Pharma Inc Recent Development Table 164. Aclaris Therapeutics Inc Company Information Table 165. Aclaris Therapeutics Inc Business Overview Table 166. Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 167. Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Product Portfolio Table 168. Aclaris Therapeutics Inc Recent Development Table 169. North America Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 170. North America Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026) & (k units) Table 171. North America Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2021-2026) Table 172. North America Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2027-2032) & (k units) Table 173. North America Tyrosine Protein Kinase JAK1 Sales Market Share Forecast by Country (2027-2032) Table 174. North America Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. North America Tyrosine Protein Kinase JAK1 Market Size by Country (2021-2026) & (US$ Million) Table 176. North America Tyrosine Protein Kinase JAK1 Market Share by Country (2021-2026) Table 177. North America Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. North America Tyrosine Protein Kinase JAK1 Market Share Forecast by Country (2027-2032) Table 179. Europe Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 180. Europe Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026) & (k units) Table 181. Europe Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2021-2026) Table 182. Europe Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2027-2032) & (k units) Table 183. Europe Tyrosine Protein Kinase JAK1 Sales Market Share Forecast by Country (2027-2032) Table 184. Europe Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Europe Tyrosine Protein Kinase JAK1 Market Size by Country (2021-2026) & (US$ Million) Table 186. Europe Tyrosine Protein Kinase JAK1 Market Share by Country (2021-2026) Table 187. Europe Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Europe Tyrosine Protein Kinase JAK1 Market Share Forecast by Country (2027-2032) Table 189. Asia-Pacific Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 190. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026) & (k units) Table 191. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2021-2026) Table 192. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2027-2032) & (k units) Table 193. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Market Share Forecast by Country (2027-2032) Table 194. Asia-Pacific Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Asia-Pacific Tyrosine Protein Kinase JAK1 Market Size by Country (2021-2026) & (US$ Million) Table 196. Asia-Pacific Tyrosine Protein Kinase JAK1 Market Share by Country (2021-2026) Table 197. Asia-Pacific Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Asia-Pacific Tyrosine Protein Kinase JAK1 Market Share Forecast by Country (2027-2032) Table 199. Latin America Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 200. Latin America Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026) & (k units) Table 201. Latin America Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2021-2026) Table 202. Latin America Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2027-2032) & (k units) Table 203. Latin America Tyrosine Protein Kinase JAK1 Sales Market Share Forecast by Country (2027-2032) Table 204. Latin America Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 205. Latin America Tyrosine Protein Kinase JAK1 Market Size by Country (2021-2026) & (US$ Million) Table 206. Latin America Tyrosine Protein Kinase JAK1 Market Share by Country (2021-2026) Table 207. Latin America Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 208. Latin America Tyrosine Protein Kinase JAK1 Market Share Forecast by Country (2027-2032) Table 209. Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 210. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026) & (k units) Table 211. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2021-2026) Table 212. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2027-2032) & (k units) Table 213. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Market Share Forecast by Country (2027-2032) Table 214. Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 215. Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size by Country (2021-2026) & (US$ Million) Table 216. Middle East and Africa Tyrosine Protein Kinase JAK1 Market Share by Country (2021-2026) Table 217. Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 218. Middle East and Africa Tyrosine Protein Kinase JAK1 Market Share Forecast by Country (2027-2032) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. Tyrosine Protein Kinase JAK1 Distributors List Table 222. Tyrosine Protein Kinase JAK1 Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. Tyrosine Protein Kinase JAK1 Image Figure 2. Global Tyrosine Protein Kinase JAK1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tyrosine Protein Kinase JAK1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Tyrosine Protein Kinase JAK1 Sales (2021-2032) & (k units) Figure 5. AZD-4205 Image Figure 6. Global AZD-4205 Sales YoY Growth (2021-2032) & (k units) Figure 7. CJ-15314 Image Figure 8. Global CJ-15314 Sales YoY Growth (2021-2032) & (k units) Figure 9. Cerdulatinib Image Figure 10. Global Cerdulatinib Sales YoY Growth (2021-2032) & (k units) Figure 11. Baricitinib Image Figure 12. Global Baricitinib Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Tyrosine Protein Kinase JAK1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Tyrosine Protein Kinase JAK1 Market Share by Type 2025 VS 2032 Figure 17. North America Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Type in 2025 Figure 18. North America Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Type in 2025 Figure 19. Europe Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Tyrosine Protein Kinase JAK1 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Eosinophilia Image Figure 30. Global Eosinophilia Sales YoY Growth (2021-2032) & (k units) Figure 31. Cutaneous Lupus Erythematosus Image Figure 32. Global Cutaneous Lupus Erythematosus Sales YoY Growth (2021-2032) & (k units) Figure 33. Hairy Cell Leukemia Image Figure 34. Global Hairy Cell Leukemia Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Tyrosine Protein Kinase JAK1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Tyrosine Protein Kinase JAK1 Market Share by Application 2025 VS 2032 Figure 39. North America Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Application in 2025 Figure 40. North America Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Application in 2025 Figure 41. Europe Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Application in 2025 Figure 42. Europe Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Application in 2025 Figure 45. Latin America Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Market Share in Value by Application in 2025 Figure 49. North America Tyrosine Protein Kinase JAK1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Tyrosine Protein Kinase JAK1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Tyrosine Protein Kinase JAK1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Tyrosine Protein Kinase JAK1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Tyrosine Protein Kinase JAK1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Tyrosine Protein Kinase JAK1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Tyrosine Protein Kinase JAK1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Tyrosine Protein Kinase JAK1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Tyrosine Protein Kinase JAK1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Tyrosine Protein Kinase JAK1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Tyrosine Protein Kinase JAK1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Tyrosine Protein Kinase JAK1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Tyrosine Protein Kinase JAK1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Tyrosine Protein Kinase JAK1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Tyrosine Protein Kinase JAK1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Tyrosine Protein Kinase JAK1 Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Tyrosine Protein Kinase JAK1 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • AZD-4205
  • CJ-15314
  • Cerdulatinib
  • Baricitinib
  • Others
Applications
  • Eosinophilia
  • Cutaneous Lupus Erythematosus
  • Hairy Cell Leukemia
  • Others
Companies covered
  • Eli Lilly and Co
  • Jiangsu Hengrui Medicine Co Ltd
  • Pfizer Inc
  • AbbVie Inc
  • AstraZeneca Plc
  • Vectura Group Plc
  • Theravance Biopharma Inc
  • Sareum Holdings Plc
  • Portola Pharmaceuticals Inc
  • Nissan Chemical Industries Ltd
  • Japan Tobacco Inc
  • Incyte Corp
  • Galapagos NV
  • Concert Pharmaceuticals Inc
  • CJ HealthCare Corp
  • Chipscreen Biosciences Ltd
  • Bristol-Myers Squibb Co
  • Astellas Pharma Inc
  • Aclaris Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tyrosine Protein Kinase JAK1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tyrosine Protein Kinase JAK1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tyrosine Protein Kinase JAK1 Market by Type
  6. 1.3.1 AZD-4205
  7. 1.3.2 CJ-15314
  8. 1.3.3 Cerdulatinib
  9. 1.3.4 Baricitinib
  10. 1.3.5 Others
  11. 1.4 Global Tyrosine Protein Kinase JAK1 Market Size by Type
  12. 1.4.1 Global Tyrosine Protein Kinase JAK1 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Tyrosine Protein Kinase JAK1 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Tyrosine Protein Kinase JAK1 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Tyrosine Protein Kinase JAK1 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Tyrosine Protein Kinase JAK1 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Tyrosine Protein Kinase JAK1 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tyrosine Protein Kinase JAK1 Industry Trends
  2. 2.2 Tyrosine Protein Kinase JAK1 Industry Drivers
  3. 2.3 Tyrosine Protein Kinase JAK1 Industry Opportunities and Challenges
  4. 2.4 Tyrosine Protein Kinase JAK1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tyrosine Protein Kinase JAK1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Tyrosine Protein Kinase JAK1 Sales (2021-2026)
  3. 3.3 Global Top Players by Tyrosine Protein Kinase JAK1 Price (2021-2026)
  4. 3.4 Global Tyrosine Protein Kinase JAK1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tyrosine Protein Kinase JAK1 Major Company Production Sites & Headquarters
  6. 3.6 Global Tyrosine Protein Kinase JAK1 Company, Product Type & Application
  7. 3.7 Global Tyrosine Protein Kinase JAK1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tyrosine Protein Kinase JAK1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tyrosine Protein Kinase JAK1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tyrosine Protein Kinase JAK1 Tier 1, Tier 2, and Tier 3
4 Tyrosine Protein Kinase JAK1 Regional Status and Outlook
  1. 4.1 Global Tyrosine Protein Kinase JAK1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tyrosine Protein Kinase JAK1 Historic Market Size by Region
  3. 4.2.1 Global Tyrosine Protein Kinase JAK1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tyrosine Protein Kinase JAK1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tyrosine Protein Kinase JAK1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tyrosine Protein Kinase JAK1 Forecasted Market Size by Region
  7. 4.3.1 Global Tyrosine Protein Kinase JAK1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tyrosine Protein Kinase JAK1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tyrosine Protein Kinase JAK1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tyrosine Protein Kinase JAK1 by Application
  1. 5.1 Tyrosine Protein Kinase JAK1 Market by Application
  2. 5.1.1 Eosinophilia
  3. 5.1.2 Cutaneous Lupus Erythematosus
  4. 5.1.3 Hairy Cell Leukemia
  5. 5.1.4 Others
  6. 5.2 Global Tyrosine Protein Kinase JAK1 Market Size by Application
  7. 5.2.1 Global Tyrosine Protein Kinase JAK1 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Tyrosine Protein Kinase JAK1 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Tyrosine Protein Kinase JAK1 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Tyrosine Protein Kinase JAK1 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Tyrosine Protein Kinase JAK1 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Tyrosine Protein Kinase JAK1 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly and Co
  2. 6.1.1 Eli Lilly and Co Company Information
  3. 6.1.2 Eli Lilly and Co Business Overview
  4. 6.1.3 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Product Portfolio
  6. 6.1.5 Eli Lilly and Co Recent Developments
  7. 6.2 Jiangsu Hengrui Medicine Co Ltd
  8. 6.2.1 Jiangsu Hengrui Medicine Co Ltd Company Information
  9. 6.2.2 Jiangsu Hengrui Medicine Co Ltd Business Overview
  10. 6.2.3 Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Product Portfolio
  12. 6.2.5 Jiangsu Hengrui Medicine Co Ltd Recent Developments
  13. 6.3 Pfizer Inc
  14. 6.3.1 Pfizer Inc Company Information
  15. 6.3.2 Pfizer Inc Business Overview
  16. 6.3.3 Pfizer Inc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  18. 6.3.5 Pfizer Inc Recent Developments
  19. 6.4 AbbVie Inc
  20. 6.4.1 AbbVie Inc Company Information
  21. 6.4.2 AbbVie Inc Business Overview
  22. 6.4.3 AbbVie Inc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AbbVie Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  24. 6.4.5 AbbVie Inc Recent Developments
  25. 6.5 AstraZeneca Plc
  26. 6.5.1 AstraZeneca Plc Company Information
  27. 6.5.2 AstraZeneca Plc Business Overview
  28. 6.5.3 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Product Portfolio
  30. 6.5.5 AstraZeneca Plc Recent Developments
  31. 6.6 Vectura Group Plc
  32. 6.6.1 Vectura Group Plc Company Information
  33. 6.6.2 Vectura Group Plc Business Overview
  34. 6.6.3 Vectura Group Plc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Vectura Group Plc Tyrosine Protein Kinase JAK1 Product Portfolio
  36. 6.6.5 Vectura Group Plc Recent Developments
  37. 6.7 Theravance Biopharma Inc
  38. 6.7.1 Theravance Biopharma Inc Company Information
  39. 6.7.2 Theravance Biopharma Inc Business Overview
  40. 6.7.3 Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  42. 6.7.5 Theravance Biopharma Inc Recent Developments
  43. 6.8 Sareum Holdings Plc
  44. 6.8.1 Sareum Holdings Plc Company Information
  45. 6.8.2 Sareum Holdings Plc Business Overview
  46. 6.8.3 Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Product Portfolio
  48. 6.8.5 Sareum Holdings Plc Recent Developments
  49. 6.9 Portola Pharmaceuticals Inc
  50. 6.9.1 Portola Pharmaceuticals Inc Company Information
  51. 6.9.2 Portola Pharmaceuticals Inc Business Overview
  52. 6.9.3 Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  54. 6.9.5 Portola Pharmaceuticals Inc Recent Developments
  55. 6.10 Nissan Chemical Industries Ltd
  56. 6.10.1 Nissan Chemical Industries Ltd Company Information
  57. 6.10.2 Nissan Chemical Industries Ltd Business Overview
  58. 6.10.3 Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Product Portfolio
  60. 6.10.5 Nissan Chemical Industries Ltd Recent Developments
  61. 6.11 Japan Tobacco Inc
  62. 6.11.1 Japan Tobacco Inc Company Information
  63. 6.11.2 Japan Tobacco Inc Business Overview
  64. 6.11.3 Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  66. 6.11.5 Japan Tobacco Inc Recent Developments
  67. 6.12 Incyte Corp
  68. 6.12.1 Incyte Corp Company Information
  69. 6.12.2 Incyte Corp Business Overview
  70. 6.12.3 Incyte Corp Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Incyte Corp Tyrosine Protein Kinase JAK1 Product Portfolio
  72. 6.12.5 Incyte Corp Recent Developments
  73. 6.13 Galapagos NV
  74. 6.13.1 Galapagos NV Company Information
  75. 6.13.2 Galapagos NV Business Overview
  76. 6.13.3 Galapagos NV Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Galapagos NV Tyrosine Protein Kinase JAK1 Product Portfolio
  78. 6.13.5 Galapagos NV Recent Developments
  79. 6.14 Concert Pharmaceuticals Inc
  80. 6.14.1 Concert Pharmaceuticals Inc Company Information
  81. 6.14.2 Concert Pharmaceuticals Inc Business Overview
  82. 6.14.3 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  84. 6.14.5 Concert Pharmaceuticals Inc Recent Developments
  85. 6.15 CJ HealthCare Corp
  86. 6.15.1 CJ HealthCare Corp Company Information
  87. 6.15.2 CJ HealthCare Corp Business Overview
  88. 6.15.3 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Product Portfolio
  90. 6.15.5 CJ HealthCare Corp Recent Developments
  91. 6.16 Chipscreen Biosciences Ltd
  92. 6.16.1 Chipscreen Biosciences Ltd Company Information
  93. 6.16.2 Chipscreen Biosciences Ltd Business Overview
  94. 6.16.3 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Product Portfolio
  96. 6.16.5 Chipscreen Biosciences Ltd Recent Developments
  97. 6.17 Bristol-Myers Squibb Co
  98. 6.17.1 Bristol-Myers Squibb Co Company Information
  99. 6.17.2 Bristol-Myers Squibb Co Business Overview
  100. 6.17.3 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Product Portfolio
  102. 6.17.5 Bristol-Myers Squibb Co Recent Developments
  103. 6.18 Astellas Pharma Inc
  104. 6.18.1 Astellas Pharma Inc Company Information
  105. 6.18.2 Astellas Pharma Inc Business Overview
  106. 6.18.3 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  108. 6.18.5 Astellas Pharma Inc Recent Developments
  109. 6.19 Aclaris Therapeutics Inc
  110. 6.19.1 Aclaris Therapeutics Inc Company Information
  111. 6.19.2 Aclaris Therapeutics Inc Business Overview
  112. 6.19.3 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Product Portfolio
  114. 6.19.5 Aclaris Therapeutics Inc Recent Developments
7 North America by Country
  1. 7.1 North America Tyrosine Protein Kinase JAK1 Sales by Country
  2. 7.1.1 North America Tyrosine Protein Kinase JAK1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026)
  4. 7.1.3 North America Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tyrosine Protein Kinase JAK1 Market Size by Country
  6. 7.2.1 North America Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tyrosine Protein Kinase JAK1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tyrosine Protein Kinase JAK1 Sales by Country
  2. 8.1.1 Europe Tyrosine Protein Kinase JAK1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tyrosine Protein Kinase JAK1 Market Size by Country
  6. 8.2.1 Europe Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tyrosine Protein Kinase JAK1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tyrosine Protein Kinase JAK1 Sales by Country
  2. 9.1.1 Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tyrosine Protein Kinase JAK1 Market Size by Country
  6. 9.2.1 Asia-Pacific Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tyrosine Protein Kinase JAK1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tyrosine Protein Kinase JAK1 Sales by Country
  2. 10.1.1 South America Tyrosine Protein Kinase JAK1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026)
  4. 10.1.3 South America Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tyrosine Protein Kinase JAK1 Market Size by Country
  6. 10.2.1 South America Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tyrosine Protein Kinase JAK1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Country
  2. 11.1.1 Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size by Country
  6. 11.2.1 Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tyrosine Protein Kinase JAK1 Value Chain Analysis
  2. 12.1.1 Tyrosine Protein Kinase JAK1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tyrosine Protein Kinase JAK1 Production Mode & Process
  7. 12.2 Tyrosine Protein Kinase JAK1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tyrosine Protein Kinase JAK1 Distributors
  10. 12.2.3 Tyrosine Protein Kinase JAK1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst